Stefaan Van Gool, MD. PhD

pediatric hematology and oncology

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
94%	37 years	9.5/10	$$$$	28	9	No

Overview

Country, City

Germany, Cologne

Health facility

Immuno-Oncology Center Cologne

Medical unit

Department of oncology, immunotherapy, and cancer vaccines

About the doctor

Prof. Dr. Stefaan Van Gool is a prominent pediatric oncologist and tumor immunologist specializing in the treatment of malignant brain tumors through innovative immunotherapy. With a career spanning over three decades, he transitioned from a distinguished academic tenure as a Full Professor at KU Leuven to leading clinical applications in translational medicine. His pioneering work in the early 2000s involved the first clinical applications of dendritic cell vaccinations for glioblastoma, a field he continues to advance by integrating these vaccines with oncolytic virus therapy and hyperthermia. Currently serving as the Medical Director at the IOZK in Cologne, Dr. Van Gool focuses on Individualized Multimodal Immunotherapy (IMI). This approach tailors treatment to each patient's tumor's unique biological profile, aiming to activate the immune system even when standard therapies have failed. He remains a prolific researcher and author, with nearly 200 scientific publications that emphasize the synergy between chemotherapy and immunotherapy. In addition to his medical expertise, he is recognized for his international advocacy in pediatric neuro-oncology and his leadership in establishing GMP-compliant production for autologous tumor vaccines.

Gallery

Advancing Glioblastoma Care: Real-World Data and Innovations in Immunotherapy

Can we monitor Immunogenic Cell Death induced with modulated electrohyperthermia..., S. van Gool

Horizons in Neuro Oncology January 2024 - Prof. Stefaan van Gool

Prof. Stefaan Van Gool, ‘Euthanasia of Children’ (‘EAS: Lessons from Belgium’ Conference, 2014)

Ep#6: Immuno Oncology – Training immune system to fight cancer with Dr. Stefaan Van Gool

Innovative strategies to fight cancer, the example of glioblastoma, with Stefaan Van Gool, MD, PhD

Resume

CV (Curriculum Vitae)

Education

1982-1989 Medical Degree, Catholic University of Leuven (KU Leuven), Belgium
1989-1993 Specialization in Pediatrics, KU Leuven
1993-1996 PhD in Medical Sciences, KU Leuven
1996-1998 Sub-specialization in Pediatric Hematology and Oncology, KU Leuven
2015 Qualified Person (GMP) in drug manufacturing, Germany

Experience

2001-2004 Head of Clinical Research, Research Foundation Flanders (FWO)
2005-2009 Coordinator, European Expert Group for High-Grade Glioma
2006-2016 Full Professor, Faculty of Medicine, Catholic University of Leuven
2008 Member, High Health Council of Belgium
2012-2015 Head of the Laboratory of Pediatric Immunology, KU Leuven
2014-2017 Co-chair, Brain Tumor Working Group of the European Society for Pediatric Oncology (SIOPE)
2015 Medical Director and Head of the Medical Team, Immune Oncological Center Cologne (IOZK), Germany
2018 Founder and Lead Physician, Praxis für Immunonkologie & Translationale Medizin, Cologne
2020 Scientific Board Member, various international oncology research consortia

Awards & Memberships

1995 Schweißguth Prize, International Society of Pediatric Oncology (SIOP)
1996 Nycomed Prize, International Society of Pediatric Oncology (SIOP)
1998 Cancer Research Prize, Rik en Nel Wouters Foundation
2001 Member, International Society of Pediatric Oncology (SIOP)
2005 Member, European Association of Neuro-Oncology (EANO)
2010 Member, Society for Neuro-Oncology (SNO)
2015 Member, Histiocyte Society
2023 Highly Cited Researcher Recognition, for contributions to Individualized Multimodal Immunotherapy